• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲脂性药物从带电多层脂质体的局部递送增强。

Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes.

作者信息

Katahira N, Murakami T, Kugai S, Yata N, Takano M

机构信息

Institute of Pharmaceutical Sciences, Hiroshima University School of Medicine, Japan.

出版信息

J Drug Target. 1999;6(6):405-14. doi: 10.3109/10611869908996847.

DOI:10.3109/10611869908996847
PMID:10937286
Abstract

To enhance the topical delivery of rhodamine B base (Rho), a model lipophilic compound, the electrostatic interaction between the positive and negative components incorporated in the liposomal bilayer was utilized. The higher in vitro permeability to Rho in rat skin was observed with positive and neutral multilamellar liposomal preparations, the former was prepared with phosphatidylcholine (PC) and stearylamine (SA) and the latter with PC alone, than that given as a solution. Negative liposome composed of PC and dicetyl phosphate (DCP) showed lower skin permeability to Rho. To enhance the Rho retention in the skin, the electrostatic interaction between SA and DCP, which was confirmed by in vitro partition study, was utilized. By pretreating the skin surface with SA solution or empty SA liposome, the skin distribution of Rho given as DCP liposome was substantially enhanced, with increase in the PC distribution into the skin. The pretreatment effect of empty SA liposome was also observed in rats in vivo. In conclusion, it was found that negative DCP liposome provides better drug retention in the skin with lower skin permeability, and the topical drug delivery from DCP liposome was further enhanced by the pretreatment of the skin surface with empty SA liposome.

摘要

为提高模型亲脂性化合物罗丹明B碱(Rho)的局部递送效果,利用了脂质体双层中正负组分之间的静电相互作用。与溶液形式给药相比,用磷脂酰胆碱(PC)和硬脂胺(SA)制备的阳性多层脂质体制剂以及单独用PC制备的中性多层脂质体制剂对Rho在大鼠皮肤中的体外渗透性更高。由PC和磷酸二鲸蜡酯(DCP)组成的阴性脂质体对Rho的皮肤渗透性较低。为提高Rho在皮肤中的滞留量,利用了体外分配研究证实的SA和DCP之间的静电相互作用。通过用SA溶液或空白SA脂质体预处理皮肤表面,以DCP脂质体形式给药的Rho在皮肤中的分布显著增强,同时PC在皮肤中的分布增加。在大鼠体内也观察到了空白SA脂质体的预处理效果。总之,发现阴性DCP脂质体在皮肤渗透性较低的情况下能实现更好的药物滞留,并且通过用空白SA脂质体预处理皮肤表面可进一步增强DCP脂质体的局部药物递送。

相似文献

1
Enhancement of topical delivery of a lipophilic drug from charged multilamellar liposomes.亲脂性药物从带电多层脂质体的局部递送增强。
J Drug Target. 1999;6(6):405-14. doi: 10.3109/10611869908996847.
2
Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.难溶性药物的脂质体制剂:载药量的优化及稳定性的环境扫描电子显微镜分析
Int J Pharm. 2004 Nov 5;285(1-2):23-34. doi: 10.1016/j.ijpharm.2004.07.010.
3
Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.尼奥斯体作为维甲酸的载体。III. 对囊泡包裹维甲酸的体外皮肤给药研究。
Int J Pharm. 2006 Mar 27;311(1-2):11-9. doi: 10.1016/j.ijpharm.2005.11.045. Epub 2006 Jan 24.
4
[Effect of liposome on permeability and drug retention of sodium fluorescein in rat skin: an experimental study].[脂质体对大鼠皮肤中荧光素钠通透性及药物滞留的影响:一项实验研究]
Di Yi Jun Yi Da Xue Xue Bao. 2003 Feb;23(2):110-3.
5
Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.局部脂质体中的他莫昔芬:研发、表征及体外评价
J Pharm Pharm Sci. 2004 Jul 16;7(2):252-9.
6
Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.脂质体作为维甲酸经皮给药的载体:药物渗透及囊泡与皮肤相互作用的体外评价
J Control Release. 2005 Mar 2;103(1):123-36. doi: 10.1016/j.jconrel.2004.11.020. Epub 2004 Dec 16.
7
Enhanced transfollicular delivery of adriamycin with a liposome and iontophoresis.
Exp Dermatol. 2004 Feb;13(2):86-92. doi: 10.1111/j.0906-6705.2004.00123.x.
8
Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.对大鼠肌肉注射不同电荷脂质体包裹的甲氨蝶呤后甲氨蝶呤的淋巴转运及药代动力学
J Microencapsul. 1995 Jul-Aug;12(4):437-46. doi: 10.3109/02652049509087256.
9
Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.电荷和脂质浓度对脂质体中烟酸甲酯体内经皮吸收的影响。
J Pharm Pharmacol. 2005 Sep;57(9):1169-76. doi: 10.1211/jpp.57.9.0011.
10
Topical liposome system bearing local anaesthetic lignocaine: preparation and evaluation.载有局部麻醉药利多卡因的局部脂质体系统:制备与评价。
J Microencapsul. 1994 May-Jun;11(3):279-86. doi: 10.3109/02652049409040457.

引用本文的文献

1
New Insights in Topical Drug Delivery for Skin Disorders: From a Nanotechnological Perspective.皮肤疾病局部给药的新见解:从纳米技术角度看
ACS Omega. 2023 May 19;8(22):19145-19167. doi: 10.1021/acsomega.2c08016. eCollection 2023 Jun 6.
2
Enhancement of the Transdermal Delivery of Nonsteroidal Anti-inflammatory Drugs Using Liposomes Containing Cationic Surfactants.使用含有阳离子表面活性剂的脂质体增强非甾体抗炎药的透皮给药
ACS Omega. 2022 Jul 12;7(29):25741-25750. doi: 10.1021/acsomega.2c03039. eCollection 2022 Jul 26.
3
Increased skin permeation efficiency of imperatorin via charged ultradeformable lipid vesicles for transdermal delivery.
通过带电荷的超可变形脂质体提高欧前胡素经皮给药的皮肤渗透效率。
Int J Nanomedicine. 2018 Feb 8;13:831-842. doi: 10.2147/IJN.S150086. eCollection 2018.
4
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex.经皮给予包载他莫昔芬的脂质体复合物对乳腺癌的抑制作用
J Nanobiotechnology. 2016 Feb 19;14:11. doi: 10.1186/s12951-016-0163-3.
5
Role of the charge, carbon chain length, and content of surfactant on the skin penetration of meloxicam-loaded liposomes.电荷、碳链长度及表面活性剂含量对载美洛昔康脂质体透皮性能的影响
Int J Nanomedicine. 2014 Apr 29;9:2005-17. doi: 10.2147/IJN.S60674. eCollection 2014.
6
Evaluation of meloxicam-loaded cationic transfersomes as transdermal drug delivery carriers.载药阳离子传递体作为透皮给药载体的美洛昔康评价。
AAPS PharmSciTech. 2013 Mar;14(1):133-40. doi: 10.1208/s12249-012-9904-2. Epub 2012 Dec 14.
7
Enhancement of topical delivery from biodegradable nanoparticles.可生物降解纳米颗粒局部给药的增强作用。
Pharm Res. 2004 Oct;21(10):1818-25. doi: 10.1023/b:pham.0000045235.86197.ef.